| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
|
Haematologica
|
2008
|
2.32
|
|
2
|
[Guidelines for diagnosis, treatment and monitoring of primary immune thrombocytopenia].
|
Med Clin (Barc)
|
2012
|
2.02
|
|
3
|
Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation.
|
Leuk Lymphoma
|
2006
|
1.65
|
|
4
|
Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.
|
Ann Hematol
|
2010
|
1.57
|
|
5
|
Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia.
|
Blood
|
2013
|
1.54
|
|
6
|
Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia.
|
Blood
|
2012
|
1.50
|
|
7
|
Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC).
|
Leuk Lymphoma
|
2013
|
1.43
|
|
8
|
Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial.
|
Haematologica
|
2013
|
1.32
|
|
9
|
Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.
|
Biol Blood Marrow Transplant
|
2006
|
1.28
|
|
10
|
Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia.
|
Biol Blood Marrow Transplant
|
2009
|
1.14
|
|
11
|
Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia.
|
J Clin Oncol
|
2009
|
1.14
|
|
12
|
Blastoschizomyces capitatus infection in patients with leukemia: report of 26 cases.
|
Clin Infect Dis
|
2004
|
1.08
|
|
13
|
Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation.
|
Biol Blood Marrow Transplant
|
2009
|
0.93
|
|
14
|
Enumeration of cytomegalovirus-specific interferongamma CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection.
|
Haematologica
|
2008
|
0.90
|
|
15
|
Case collection study of the safety of AmBisome in association with voriconazole in the treatment of patients with invasive fungal infection.
|
Rev Esp Quimioter
|
2010
|
0.89
|
|
16
|
Fungemia due to Candida guilliermondii in a pediatric and adult population during a 12-year period.
|
Diagn Microbiol Infect Dis
|
2007
|
0.88
|
|
17
|
Voriconazole in the management of nosocomial invasive fungal infections.
|
Ther Clin Risk Manag
|
2006
|
0.86
|
|
18
|
Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
|
J Antimicrob Chemother
|
2002
|
0.85
|
|
19
|
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
|
Haematologica
|
2002
|
0.83
|
|
20
|
Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination.
|
Mediterr J Hematol Infect Dis
|
2012
|
0.82
|
|
21
|
FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies.
|
Leuk Res
|
2002
|
0.82
|
|
22
|
Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns.
|
J Clin Microbiol
|
2006
|
0.82
|
|
23
|
Characteristics of and risk factors for pneumonia in patients with hematological malignancies developing fever after autologous blood stem cell transplantation.
|
Leuk Lymphoma
|
2007
|
0.81
|
|
24
|
Use of eltrombopag after romiplostim in primary immune thrombocytopenia.
|
Br J Haematol
|
2014
|
0.81
|
|
25
|
Survival of hematological patients after discharge from the intensive care unit: a prospective observational study.
|
Crit Care
|
2013
|
0.81
|
|
26
|
Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain.
|
BMC Pharmacol Toxicol
|
2014
|
0.81
|
|
27
|
Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients.
|
Antivir Ther
|
2011
|
0.80
|
|
28
|
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.
|
Am J Hematol
|
2015
|
0.80
|
|
29
|
Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia.
|
Biol Blood Marrow Transplant
|
2010
|
0.79
|
|
30
|
Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?
|
Ther Clin Risk Manag
|
2008
|
0.79
|
|
31
|
Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation.
|
Biol Blood Marrow Transplant
|
2014
|
0.79
|
|
32
|
Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: a multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study.
|
Br J Haematol
|
2013
|
0.78
|
|
33
|
A study of incidence and characteristics of infections in 476 patients from a single center undergoing autologous blood stem cell transplantation.
|
Int J Hematol
|
2007
|
0.78
|
|
34
|
Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.
|
Biol Blood Marrow Transplant
|
2009
|
0.77
|
|
35
|
Antifungal prophylaxis in the haematological patient: a practical approach.
|
Rev Esp Quimioter
|
2012
|
0.77
|
|
36
|
Long-term management of chronic immune thrombocytopenic purpura in adults.
|
Int J Gen Med
|
2010
|
0.77
|
|
37
|
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain.
|
BMC Infect Dis
|
2012
|
0.77
|
|
38
|
Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab.
|
Expert Rev Hematol
|
2011
|
0.76
|
|
39
|
Inadequate references in recent article.
|
Am J Health Syst Pharm
|
2012
|
0.75
|
|
40
|
[Reply].
|
Med Clin (Barc)
|
2012
|
0.75
|
|
41
|
Update on bacteraemia in oncology and hematology.
|
Enferm Infecc Microbiol Clin
|
2011
|
0.75
|
|
42
|
[Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?].
|
Enferm Infecc Microbiol Clin
|
2011
|
0.75
|
|
43
|
Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
|
Rev Esp Quimioter
|
2013
|
0.75
|
|
44
|
[Pocket guide to invasive mycoses in onco-hematologic patients].
|
Rev Iberoam Micol
|
2009
|
0.75
|
|
45
|
Heart transplantation in a patient with systemic mastocytosis.
|
J Heart Lung Transplant
|
2008
|
0.75
|